Ondine Biomedical Inc. (LON:OBI – Get Free Report) shares traded down 2.4% on Friday . The company traded as low as C$13.05 and last traded at C$13.43. 450,866 shares were traded during trading, an increase of 4% from the average session volume of 434,064 shares. The stock had previously closed at C$13.75.
Ondine Biomedical Stock Performance
The stock has a market capitalization of C$6.97 billion, a price-to-earnings ratio of -1.92 and a beta of 0.32. The company has a current ratio of 1.23, a quick ratio of 8.26 and a debt-to-equity ratio of 11.85. The firm has a 50-day moving average of C$14.28 and a 200-day moving average of C$11.98.
About Ondine Biomedical
Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target.
Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada.
Featured Stories
- Five stocks we like better than Ondine Biomedical
- Netflix’s Big Sell-Off May Be Sending the Wrong Signal
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
